Company intelligence / Profile preview

Acacia Research

New York City, New York, United States

Ownership: Private
Employees: ~170
Development stage: Other

Overview

Acacia Research is a publicly traded company specializing in investing in undervalued IP-rich companies, especially in technology, life sciences, and healthcare; it monetizes patents and invests in private equity assets such as NovaBiotics, Immunocore, Arix Bioscience, Viamet, and AMO Pharma, some of which have late-stage or commercialized assets.

Therapeutic areas: OncologyInfectious DiseasesImmunologyRare Diseases
Modalities: Small moleculeBiologicAntibodyAmino-based therapyTCR-based therapy
Industry: Investors

Partnerships

Johnson & Johnson (via Cardio Access LLC; licensing agreement)Various partnerships through patent licensing (over 1200 agreements)

Beyond the preview

Go deeper on Acacia Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acacia Research.

Explore the full profile